Trial intelligence / Profile preview

Insuman Implantable vs Insuplant in Type 1 Diabetes

NCT01194882Phase 3Completed

Sponsor
Sanofi
Start
Nov 2010
Primary completion
Feb 2018
Modality
Recombinant Proteins and Enzymes
Countries
4
01

Overview

A Phase 3 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Nov 2010; status: completed.

02

Drugs

human insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01194882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01194882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call